Mizuho Securities USA LLC Increases Stake in Cardinal Health, Inc. (NYSE:CAH)

Mizuho Securities USA LLC increased its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 45.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,937 shares of the company's stock after acquiring an additional 7,125 shares during the period. Mizuho Securities USA LLC's holdings in Cardinal Health were worth $2,713,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. State Street Corp boosted its holdings in shares of Cardinal Health by 4.6% during the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock valued at $1,566,913,000 after acquiring an additional 627,253 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after purchasing an additional 42,082 shares in the last quarter. Amundi grew its holdings in shares of Cardinal Health by 5.5% during the fourth quarter. Amundi now owns 2,116,291 shares of the company's stock worth $259,309,000 after purchasing an additional 110,605 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Cardinal Health by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company's stock worth $179,653,000 after purchasing an additional 44,386 shares during the last quarter. Finally, Two Sigma Advisers LP grew its holdings in Cardinal Health by 47.9% during the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock worth $118,197,000 after acquiring an additional 346,362 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Remove Ads

Cardinal Health Stock Performance

Shares of Cardinal Health stock traded down $0.22 during trading hours on Friday, reaching $136.43. The company's stock had a trading volume of 1,873,170 shares, compared to its average volume of 2,104,261. The company has a market capitalization of $32.96 billion, a P/E ratio of 25.45, a P/E/G ratio of 1.49 and a beta of 0.66. The stock's fifty day simple moving average is $128.16 and its two-hundred day simple moving average is $120.59. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $139.81.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio is presently 37.69%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CAH. Morgan Stanley lifted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a report on Friday, January 31st. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target on the stock in a research report on Tuesday, January 7th. Argus set a $148.00 price target on Cardinal Health in a research note on Tuesday, February 4th. JPMorgan Chase & Co. lifted their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Finally, Wells Fargo & Company increased their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and a consensus price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.